Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Prevention of diabetic renal disease with special reference to microalbuminuria.
|
Lancet
|
1995
|
4.06
|
2
|
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).
|
J Clin Invest
|
2001
|
2.20
|
3
|
A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia.
|
Am J Cardiol
|
1997
|
1.77
|
4
|
Reduced bone mass in daughters of women with osteoporosis.
|
N Engl J Med
|
1989
|
1.70
|
5
|
Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat.
|
Diabetes
|
1991
|
1.58
|
6
|
Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat.
|
Diabetologia
|
1989
|
1.57
|
7
|
Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat.
|
Diabetologia
|
2003
|
1.55
|
8
|
The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat.
|
Diabetologia
|
1995
|
1.46
|
9
|
Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods.
|
Diabetologia
|
2006
|
1.42
|
10
|
Progressive decline in renal function in diabetic patients with and without albuminuria.
|
Diabetes
|
1994
|
1.40
|
11
|
Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes.
|
Med J Aust
|
2001
|
1.39
|
12
|
Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats.
|
Kidney Int
|
1998
|
1.36
|
13
|
Influence of age on the presentation and outcome of acidotic and hyperosmolar diabetic emergencies.
|
Intern Med J
|
2002
|
1.35
|
14
|
A comparison of guanacline with methyldopa in the treatment of hypertension.
|
Med J Aust
|
1968
|
1.21
|
15
|
Methyldopa and haemolytic anaemia.
|
Med J Aust
|
1967
|
1.13
|
16
|
Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products.
|
J Clin Invest
|
1997
|
1.12
|
17
|
Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage.
|
Diabetes
|
2000
|
1.09
|
18
|
The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes.
|
Diabet Med
|
2007
|
1.08
|
19
|
Effect of thyroid status on ouabain binding to the human lymphocyte.
|
J Clin Endocrinol Metab
|
1982
|
1.06
|
20
|
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.
|
Diabetologia
|
2000
|
1.03
|
21
|
Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C.
|
Diabetes
|
2000
|
1.03
|
22
|
Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate.
|
Diabetologia
|
2005
|
0.97
|
23
|
Clinical, biochemical and histological observations on the effect of porcine calcitonin in Paget's disease of bone.
|
Aust N Z J Med
|
1977
|
0.97
|
24
|
Patterns of glycaemic control in Australian primary care (NEFRON 8).
|
Intern Med J
|
2008
|
0.97
|
25
|
Renoprotective effects of a novel inhibitor of advanced glycation.
|
Diabetologia
|
2001
|
0.97
|
26
|
Microalbuminuria: prognostic and therapeutic implications in diabetes mellitus.
|
Diabet Med
|
1994
|
0.96
|
27
|
Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.
|
Diabet Med
|
1996
|
0.96
|
28
|
Increased epidermal growth factor in experimental diabetes related kidney growth in rats.
|
Diabetologia
|
1997
|
0.95
|
29
|
Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patients.
|
Atherosclerosis
|
1995
|
0.94
|
30
|
Plasma renin levels and vascular complications in hypertension.
|
Br Med J
|
1973
|
0.94
|
31
|
Effects of genetic hypertension on diabetic nephropathy in the rat--functional and structural characteristics.
|
J Hypertens
|
1988
|
0.94
|
32
|
Inflammation, hepatic enzymes and resistance training in individuals with metabolic risk factors.
|
Diabet Med
|
2009
|
0.92
|
33
|
Early nephropathy predicts vision-threatening retinal disease in patients with type I diabetes mellitus.
|
J Am Soc Nephrol
|
1998
|
0.92
|
34
|
Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.
|
Diabetes
|
1998
|
0.91
|
35
|
Salt supplementation blunts the blood pressure response to telmisartan with or without hydrochlorothiazide in hypertensive patients with type 2 diabetes.
|
Diabetologia
|
2010
|
0.91
|
36
|
The effect of acute exercise on undercarboxylated osteocalcin in obese men.
|
Osteoporos Int
|
2010
|
0.91
|
37
|
The CARI guidelines. Assessment of kidney function in type 2 diabetes.
|
Nephrology (Carlton)
|
2010
|
0.90
|
38
|
Alterations in renal degradation of albumin in early experimental diabetes in the rat: a new factor in the mechanism of albuminuria.
|
Clin Sci (Lond)
|
1998
|
0.90
|
39
|
Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.
|
Diabetologia
|
1997
|
0.89
|
40
|
Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.
|
Diabetes
|
1997
|
0.89
|
41
|
Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding.
|
Kidney Int
|
1999
|
0.89
|
42
|
Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
|
J Clin Endocrinol Metab
|
1992
|
0.89
|
43
|
Differential renal protein clearance in diabetes.
|
Diabetes
|
1973
|
0.88
|
44
|
Fractional clearance of albumin is influenced by its degradation during renal passage.
|
Clin Sci (Lond)
|
1997
|
0.88
|
45
|
Diabetic vascular complications.
|
Clin Exp Pharmacol Physiol
|
1997
|
0.88
|
46
|
Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat.
|
Am J Hypertens
|
1988
|
0.87
|
47
|
Functional erythropoietin deficiency in patients with Type 2 diabetes and anaemia.
|
Diabet Med
|
2006
|
0.87
|
48
|
Progression of proteinuria in type 1 and type 2 diabetes.
|
Diabet Med
|
1988
|
0.87
|
49
|
Pathogenesis and intervention strategies in diabetic retinopathy.
|
Clin Experiment Ophthalmol
|
2001
|
0.86
|
50
|
Renal sodium handling and responsiveness of plasma renin levels in hypertension.
|
Clin Sci
|
1969
|
0.86
|
51
|
Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.
|
J Am Soc Nephrol
|
2001
|
0.86
|
52
|
Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment.
|
Kidney Int
|
1996
|
0.86
|
53
|
Anaphylaxis to suxamethonium. A case report.
|
Br J Anaesth
|
1967
|
0.86
|
54
|
Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
|
Diabetes
|
1990
|
0.85
|
55
|
Metabolism and blood levels following infusion of a radioactive analog of angiotensin.
|
Am J Physiol
|
1968
|
0.85
|
56
|
Glomerular filtration rate in streptozocin-induced diabetic rats. Role of exchangeable sodium, vasoactive hormones, and insulin therapy.
|
Diabetes
|
1990
|
0.85
|
57
|
Albuminuric and non-albuminuric pathways to renal impairment in diabetes.
|
Minerva Endocrinol
|
2005
|
0.85
|
58
|
Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbit.
|
Atherosclerosis
|
1998
|
0.85
|
59
|
Phaeochromocytoma in the elderly: a poorly recognised entity?
|
Br Med J (Clin Res Ed)
|
1986
|
0.85
|
60
|
Localization of secreted protein acidic and rich in cysteine (SPARC) expression in the rat eye.
|
Connect Tissue Res
|
1999
|
0.84
|
61
|
Effect of early menopause on bone mass in normal women and patients with osteoporosis.
|
Am J Med
|
1988
|
0.84
|
62
|
Proteolysis of insulin-like growth factor-binding protein-3 is increased in urine from patients with diabetic nephropathy.
|
J Clin Endocrinol Metab
|
2000
|
0.83
|
63
|
The development of Cushing's syndrome from a previously silent pituitary tumour.
|
Aust N Z J Med
|
1987
|
0.83
|
64
|
Medical adrenalectomy with aminoglutethimide in the management of advanced breast cancer.
|
Med J Aust
|
1981
|
0.83
|
65
|
The CARI guidelines. Prevention and management of chronic kidney disease in type 2 diabetes.
|
Nephrology (Carlton)
|
2010
|
0.82
|
66
|
Effect of puberty on initial kidney growth and rise in kidney IGF-I in diabetic rats.
|
Diabetes
|
1990
|
0.81
|
67
|
Performance of formulas for estimating glomerular filtration rate in Indigenous Australians with and without Type 2 diabetes: the eGFR Study.
|
Diabet Med
|
2014
|
0.81
|
68
|
Extracellular matrix and its interactions in the diabetic kidney: a molecular biological approach.
|
J Diabetes Complications
|
1996
|
0.81
|
69
|
High sodium and low potassium intake in patients with Type 2 diabetes.
|
Diabet Med
|
2010
|
0.81
|
70
|
Serum total renin is increased before microalbuminuria in diabetes.
|
Kidney Int
|
1996
|
0.81
|
71
|
Increased bone mineral density in Aboriginal and Torres Strait Islander Australians: impact of body composition differences.
|
Bone
|
2012
|
0.81
|
72
|
Low serum C4 concentrations and microangiopathy in type I and type II diabetes.
|
Br Med J (Clin Res Ed)
|
1986
|
0.80
|
73
|
Interlaboratory variation of GHb assays in Victoria, Australia.
|
Diabetes Care
|
1996
|
0.80
|
74
|
A comparison of the plasma disappearance of iohexol and 99mTc-DTPA for the measurement of glomerular filtration rate (GFR) in diabetes.
|
Aust N Z J Med
|
1999
|
0.80
|
75
|
A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes.
|
Diabetologia
|
1999
|
0.80
|
76
|
Prediction of persistent microalbuminuria in patients with diabetes mellitus.
|
J Diabetes Complications
|
1993
|
0.80
|
77
|
Long-term use of intranasal insulin in insulin-dependent diabetic patients.
|
Diabetes Care
|
1988
|
0.80
|
78
|
Urinary transforming growth factor-beta in patients with diabetic nephropathy: implications for the pathogenesis of tubulointerstitial pathology.
|
Nephrol Dial Transplant
|
2001
|
0.80
|
79
|
Spectrum of proteinuria in type I and type II diabetes.
|
Diabetes Care
|
1987
|
0.80
|
80
|
Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat.
|
Diabetes Res
|
1994
|
0.79
|
81
|
The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
|
Diabetes
|
1993
|
0.79
|
82
|
SPARC gene expression is reduced in early diabetes-related kidney growth.
|
Kidney Int
|
1995
|
0.79
|
83
|
Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery.
|
Clin Sci (Lond)
|
2001
|
0.78
|
84
|
Antihypertensive therapy in a model combining spontaneous hypertension with diabetes.
|
Kidney Int
|
1992
|
0.78
|
85
|
Effect of glycation of albumin on its renal clearance in normal and diabetic rats.
|
Kidney Int
|
1988
|
0.78
|
86
|
Effects of intranasal insulin in non-obese type II diabetics.
|
Diabetes Res Clin Pract
|
1987
|
0.77
|
87
|
Estimating dual-energy X-ray absorptiometry-derived total body skeletal muscle mass using single-slice abdominal magnetic resonance imaging in obese subjects with and without diabetes: a pilot study.
|
Eur J Clin Nutr
|
2012
|
0.77
|
88
|
Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
|
Invest Ophthalmol Vis Sci
|
1996
|
0.77
|
89
|
The CARI guidelines. Cost-effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetes.
|
Nephrology (Carlton)
|
2010
|
0.77
|
90
|
Ramipril and aminoguanidine restore renal lysosomal processing in streptozotocin diabetic rats.
|
Diabetologia
|
2001
|
0.77
|
91
|
Measurement of iohexol by capillary electrophoresis: minimizing practical problems encountered.
|
Ann Clin Biochem
|
2000
|
0.77
|
92
|
Sodium balance, plasma renin, and aldosterone in hypertension.
|
Circ Res
|
1970
|
0.77
|
93
|
Detection of microalbuminuria in diabetic patients by urinary dipstick.
|
Diabetes Res Clin Pract
|
1997
|
0.77
|
94
|
The effects of dietary cholesterol on experimental diabetic nephropathy.
|
Diabetes Res
|
1993
|
0.77
|
95
|
Complementary effects of pravastatin and nicotinic acid in the treatment of combined hyperlipidaemia in diabetic and non-diabetic patients.
|
J Cardiovasc Risk
|
1994
|
0.77
|
96
|
Oxygen (O2) kinetics during early recovery from peak exercise in patients with Type 2 diabetes.
|
Diabet Med
|
2011
|
0.77
|
97
|
Immuno-unreactive albumin excretion increases in streptozotocin diabetic rats.
|
Am J Kidney Dis
|
2001
|
0.77
|
98
|
Day-night blood pressure variation in normotensive, normoalbuminuric type I diabetic subjects. Dippers and non-dippers.
|
Diabetes Care
|
1994
|
0.77
|
99
|
Diabetes-related renal growth and IGF-I accumulation in castrated rats.
|
Diabetes Res Clin Pract
|
1991
|
0.76
|
100
|
Lack of effect of gliclazide on early diabetic nephropathy and retinopathy: a two-year controlled study.
|
Diabetes Res Clin Pract
|
1987
|
0.76
|
101
|
The cyclic AMP response to glucagon. Comparison of tissue and plasma cyclic AMP levels in the rabbit.
|
Diabetes
|
1977
|
0.76
|
102
|
Carbimazole-induced agranulocytosis: does antineutrophil cytoplasmic antibody have a role?
|
Intern Med J
|
2010
|
0.76
|
103
|
Focal induction of IGF binding proteins in proximal tubules of diabetic rat kidney.
|
Diabetes
|
1992
|
0.76
|
104
|
Kidney insulin-like growth factor-I mRNA levels are increased in postpubertal diabetic rats.
|
J Endocrinol
|
1991
|
0.76
|
105
|
Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
|
J Clin Endocrinol Metab
|
1991
|
0.76
|
106
|
Primary prevention of stroke.
|
N Engl J Med
|
1996
|
0.75
|
107
|
Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate.
|
J Diabetes Complications
|
1996
|
0.75
|
108
|
Hyperlipidaemia increases albuminuria in hypertensive and normotensive rats.
|
Clin Exp Pharmacol Physiol
|
1990
|
0.75
|
109
|
Cyclic AMP and gastric acid secretion in the dog.
|
Aust N Z J Surg
|
1982
|
0.75
|
110
|
The biguanides: action and clinical indications.
|
Aust Fam Physician
|
1976
|
0.75
|
111
|
Relationship between ambulatory blood pressure and albuminuria in normal subjects.
|
Am J Hypertens
|
1991
|
0.75
|
112
|
The treatment of hirsutism: experience with cyproterone acetate and spironolactone.
|
Australas J Dermatol
|
1985
|
0.75
|
113
|
Ramipril reduces albuminuria in diabetic rats fed a high protein diet.
|
Clin Exp Pharmacol Physiol
|
1989
|
0.75
|
114
|
Nuclear scanning in the diagnosis and localization of parathyroid adenomas.
|
Med J Aust
|
1986
|
0.75
|
115
|
Effects of insulin therapy and glycemic control on distribution of HDL alpha and pre-beta subfractions in non insulin-dependent diabetic subjects.
|
Nutr Metab Cardiovasc Dis
|
1999
|
0.75
|
116
|
Diabetic dyslipidaemia. Australian Diabetes Society position statement.
|
Med J Aust
|
1995
|
0.75
|
117
|
Dissociation of blood pressure and albuminuria in normal subjects infused with angiotensin II and noradrenaline.
|
Clin Exp Pharmacol Physiol
|
1993
|
0.75
|
118
|
Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.
|
J Clin Endocrinol Metab
|
1996
|
0.75
|
119
|
Plasma angiotensinase activity in relation to the breakdown of phenylthiocarbamyl-angiotensin II amide in hypertensive and normotensive patients.
|
Cardiovasc Res
|
1968
|
0.75
|
120
|
An evaluation of secondary failure to tolbutamide therapy.
|
Aust N Z J Med
|
1974
|
0.75
|
121
|
Angiotensin converting enzyme inhibitors and diabetic renal disease. ACE inhibitors may prevent progression from incipient to clinical nephropathy.
|
Med J Aust
|
1994
|
0.75
|
122
|
The effect of modifying the combination of insulin with rat adipose cells on the intracellular levels of cyclic AMP.
|
Clin Sci Mol Med
|
1974
|
0.75
|
123
|
Treatment of Paget's disease of bone with porcine calcitonin.
|
Med J Aust
|
1974
|
0.75
|
124
|
Androgens in women: source, nature and investigation.
|
Australas J Dermatol
|
1985
|
0.75
|
125
|
Treatment of hypertension in diabetes.
|
Saudi J Kidney Dis Transpl
|
2008
|
0.75
|
126
|
Glomerular filtration rate in early experimental diabetes.
|
J Diabet Complications
|
1988
|
0.75
|
127
|
Coma and thyroid dysfunction.
|
Anaesth Intensive Care
|
1992
|
0.75
|
128
|
Tachyphylaxis to alpha- and beta-angiotensin in dogs perfused with Ringer's solution or blood.
|
Circ Res
|
1968
|
0.75
|
129
|
Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
|
Med J Aust
|
1990
|
0.75
|
130
|
Semi-quantitative determination of microalbuminuria by urinary dipstick.
|
Aust N Z J Med
|
1992
|
0.75
|
131
|
Diabetes and hypertension: prognostic and therapeutic considerations.
|
Blood Press
|
1995
|
0.75
|
132
|
Effect of glycaemic control on glomerular filtration rate in the streptozotocin diabetic rat.
|
Clin Exp Pharmacol Physiol
|
1988
|
0.75
|
133
|
Long-term intraindividual variability of serum lipids in patients with type I and type II diabetes.
|
J Diabetes Complications
|
1998
|
0.75
|
134
|
The effects of sodium loading and deprivation on plasma renin and plasma and urinary aldosterone in hypertension.
|
Clin Sci
|
1972
|
0.75
|
135
|
Longitudinal evaluation of the renal clearance of glycated albumin in the diabetic rat.
|
Diabetes Res Clin Pract
|
1990
|
0.75
|
136
|
Blood angiotensinase activity in relation to the breakdown of angiotensin II amide and nonisotopic phenylthiocarbamyl-angiotensin II amide in hypertensive and normotensive patients.
|
Cardiovasc Res
|
1968
|
0.75
|
137
|
Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study.
|
Diabetes Res Clin Pract
|
1988
|
0.75
|
138
|
The use of simvastatin, an HMG CoA reductase inhibitor, in older patients with hypercholesterolemia and atherosclerosis.
|
J Am Geriatr Soc
|
1990
|
0.75
|
139
|
In vivo assessment of an animal model of diabetic cataract: medical intervention studies.
|
Dev Ophthalmol
|
1994
|
0.75
|
140
|
Accelerated progression of diabetic nephropathy in the spontaneously hypertensive streptozotocin diabetic rat.
|
Clin Exp Pharmacol Physiol
|
1986
|
0.75
|
141
|
Two types of insulin receptors mediating opposite effects on cyclic-amp in fat cells of the rat.
|
Horm Metab Res
|
1974
|
0.75
|
142
|
Anomalous decrease in dextran sulfate clearance in the diabetic rat kidney.
|
Am J Physiol
|
1998
|
0.75
|
143
|
Prolonged hypercalcemia following acute renal failure.
|
Clin Nephrol
|
1975
|
0.75
|
144
|
Thiazolidinediones and congestive heart failure--exacerbation or new onset of left ventricular dysfunction?
|
Diabet Med
|
2004
|
0.75
|
145
|
Intermittent diabetic microalbuminuria: association with blood pressure, glycemic control, and protein intake.
|
J Diabet Complications
|
1989
|
0.75
|